For instance, serum levels of carcinoembryonic antigen (CEA) have been reported to significantly increase in patients suffering from both colorectal cancer (Su et al., 2012) and glioma (Suzuki & Tanaka, 1980). This evidence concerns the gene CEACAM5 and central nervous system cancer.